0.861
Purple Biotech Ltd Adr (PPBT) 最新ニュース
Healthy Upside Potential: VYNE Therapeutics Inc (VYNE) - setenews.com
Purple Biotech stock soars after manufacturing milestone for tri-specific antibody - Investing.com
Dow Surges 250 Points; Verizon Posts Mixed Q3 Results - Benzinga
Purple Biotech Announces Receipt of Nasdaq Minimum Bid Price Notification - GlobeNewswire Inc.
Is Banco Santander S.A. Sponsored ADR stock a top dividend aristocrat candidateEarnings Recap Report & AI Forecast Swing Trade Picks - newser.com
Purple Biotech Enters New ATM Agreement with H.C. Wainwright - The Globe and Mail
Purple Biotech Ltd. enters $2.3M ATM - Investing.com
Purple Biotech (NASDAQ:PPBT) Trading Down 12.3% – Here’s Why - Defense World
Purple Biotech (PPBT) Stock Price, News & Analysis - MarketBeat
Clinical-Stage Cancer Drug Developer Purple Biotech to Present at Major Healthcare Conference - Stock Titan
Purple Biotech (NASDAQ:PPBT) Trading Down 4.9% Following Weak Earnings - Defense World
PPBT’s Stock Market Expedition: Traversing Gains and Losses in 2025 - investchronicle.com
Purple Biotech Highlights Clinical Milestones and Pipeline Progress in H1 2025 - TipRanks
Purple Biotech (NASDAQ:PPBT) Shares Down 2% – Here’s Why - Defense World
Kingswood Wealth Advisors LLC Has $44,000 Holdings in Purple Biotech Ltd. Sponsored ADR (NASDAQ:PPBT) - Defense World
H.C. Wainwright lifts Purple Biotech stock target to $34 By Investing.com - Investing.com South Africa
H.C. Wainwright lifts Purple Biotech stock target to $34 - Investing.com
Purple Biotech: Advancing Next-Generation Cancer Therapies - roscoeviewjournal.com
Purple Biotech appoints Shai Lankry as new CFO By Investing.com - Investing.com South Africa
Purple Biotech appoints Shai Lankry as new CFO - Investing.com
Best upcoming stock splits and reverse splits 2024 - Investorsobserver
PPBT Stock Surges 150% on Superior Efficacy of PDAC Combo Therapy - Nasdaq
Do You Know What To Trade This Month? - StocksToTrade
PPBT stock touches 52-week low at $3.52 amid market challenges - Investing.com
PPBT stock touches 52-week low at $5.89 amid market challenges - Investing.com
What Makes Purple Biotech (PPBT) a New Buy Stock - Yahoo Finance
Purple Biotech stock target cut on trial cohort issue - Investing.com
95 Promising Stocks You Can Currently Buy for Less Than $5 Per Share - GOBankingRates
Purple Biotech (PPBT) Stock Forecast and Price Target 2025 - MarketBeat
Here's Why Purple Biotech Ltd. Sponsored ADR (PPBT) Could be Great Choice for a Bottom Fisher - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
Purple Biotech LtdADR (PPBT) News, Articles, Events & Latest Updates - Stocktwits
What is the current Price Target and Forecast for Purple Biotech (PPBT) - Zacks Investment Research
Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici
Purple Biotech Stock: Should I invest? - Value The Markets
PPBT Stock Price and Chart — TASE:PPBT - TradingView
Purple Biotech (PPBT) Competitors and Alternatives 2025 - MarketBeat
Purple Biotech Ltd (PPBT) Stock Price, News, Quote & History - Yahoo! Finance Canada
PPBT Stock Price and Chart — NASDAQ:PPBT - TradingView
Salarius Pharmaceuticals (SLRX) Short Interest Ratio and Volume 2025 - MarketBeat
Pre-Market Stock Quote Data - Nasdaq
Can-Fite BioPharma Ltd. (CANF) Stock Price, News, Quote & History - Yahoo
大文字化:
|
ボリューム (24 時間):